Elequin Capital LP Glaukos Corp Transaction History

Elequin Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$89.48 - $118.35 $14,227 - $18,817	159 New	159 $18,000
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $21,253 - $24,280	-307 Reduced 95.94%	13 $0
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $14,540 - $22,787	320 New	320 $22,000
Q4 2022 Feb 09, 2023	BUY	$40.82 - $57.75 $489 - $693	12 New	12 $0
Q2 2022 Aug 11, 2022	BUY	$34.86 - $63.77 $104 - $191	3 Added 13.64%	25 $1,000
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $975 - $1,272	22 New	22 $1,000

349

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.43B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

Stay updated on Elequin Capital LP with notifications on news.